TickerFactsScreenerDevelopers

Altimmune, Inc. (ALT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: $3.15M2010: $12.21M2011: $15.85M2012: $11.67M2013: $7.34M2014: $18.27M2015: $43.13M2016: $32.21M2017: $39.40M2018: $48.31M2019: $45.52M2020: $225.88M2021: $199.13M2022: $185.29M2023: $194.10M2024: $123.51M2025: $224.89M$224.89M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$224.89M+82.1%
2024$123.51M-36.4%
2023$194.10M+4.8%
2022$185.29M-7.0%
2021$199.13M-11.8%
2020$225.88M+396.2%
2019$45.52M-5.8%
2018$48.31M+22.6%
2017$39.40M+22.3%
2016$32.21M-25.3%
2015$43.13M+136.0%
2014$18.27M+149.1%
2013$7.34M-37.2%
2012$11.67M-26.4%
2011$15.85M+29.8%
2010$12.21M+287.3%
2009$3.15M—